WOBURN, Mass.--(EON: Enhanced Online News)--Courtagen Life Sciences and Medicinal Genomics today announced a partnership with TheAnswerPage.com to provide continuing medical education (CME) credits to physicians and other healthcare professionals for the upcoming CannMed 2017 Personalized Cannabinoid Medicine Conference to be held at the Joseph B. Martin Conference Center at Harvard Medical School in Boston on April 9-11, 2017.
“We created the CannMed conference with the mission to share the current state-of-the-art in medical practice and scientific advances with respect to cannabis medicine”
“The medical cannabis CME course offered at the CannMed 2107 is perfect for all healthcare providers,” said Stephen B. Corn, MD, Founding Editor-in-Chief of TheAnswerPage. Corn notes that, “Whether or not doctors or other healthcare providers have any intention of recommending medical cannabis for patient care, they all need to be well educated in this clinical area because their patients will be seeking their expert advice and guidance for this important medication. Further, some patients may already be utilizing medical cannabis and doctors and other healthcare providers will need to be aware of the physiological effects of cannabis as well as potential drug interactions. As such, expertise in medical cannabis will be paramount for most doctors, pharmacists, nurses, and other healthcare providers if they wish to continue to be that respected guide for their patients’ healthcare.”
CannMed conference attendees are eligible for the CME benefits and will learn the latest medical cannabis information from Courtagen’s invited team of experts. In addition to being able to earn AMA PRA Category 1 CME Credits™ registered attendees will be provided with access to TheAnswerPage’s medical cannabis educational library for an entire year, including updates and new information.
“We created the CannMed conference with the mission to share the current state-of-the-art in medical practice and scientific advances with respect to cannabis medicine,” said Doug Kennedy, Conference Director for CannMed. “We’re excited to be working with the experts at the TheAnswerPage to provide a CME option and give practicing doctors, nurses, and pharmacists another way to benefit from the conference.”
TheAnswerPage is the sole provider for the New York State required medical marijuana certification course, and the sole educational partner to the Florida Medical Association and Florida Osteopathic Medical Association in the creation of their state-required courses. In addition, at the recommendation of Dr. Raphael Mechoulam, the “Father of Marijuana Research”, the Israeli Ministry of Health is featuring their content for Israel’s National Healthcare Provider Cannabis Program.
In addition to the CME option, every medical professional registering under the Clinical Provider Rate or the Healthcare Professional Rate is entitled to a $50 discount off the listed rate (including the early bird discount rate) and may also select a non-profit partner to receive a $50 contribution from Courtagen through the Courtagen Gives Back Program. Program participants include:
- The Epilepsy Foundation
- Autism Speaks
- The Young and Brave
- Veterans For Cannabis Foundation
Early-bird discounts are available until February 21st. For additional details or to register for CannMed 2017, visit http://www.cannmedevents.com/
TheAnswerPage.com, founded by Stephen B. Corn, MD, is a continuing medical education (CME) website that has been providing AMA PRA Category 1 CME™ accredited content worldwide since 1998 and has become a recognized leader in providing unbiased peer-reviewed medical content focused on medical cannabis, pain and the opioid epidemic. To help physicians, nurses and pharmacists meet the needs of their patients, in 2012 Stephen B. Corn, MD and Meredith Fisher-Corn, MD, Editor-in-Chief of TheAnswerPage, developed an extensive library of medical cannabis syllabus topics, including content written by world-renowned medical cannabis researchers and clinicians. TheAnswerPage’s accredited educational courses address the endocannabinoid system, phytocannabinoids, the administration of cannabinoid medicines, the physiological and cognitive effects of cannabinoid medicines, the therapeutic uses of cannabinoid medicines in various diseases, and much, much more. For more information, please visit: https://www.theanswerpage.com/
About Medicinal Genomics Corporation
Medicinal Genomics Corporation applies state-of-the-art life science technology to cannabis plant genetics. Our products, based on Next Generation DNA Sequencing technology, help growers, dispensaries, and safety testing laboratories characterize and understand the quality of medicinal cannabis. Medicinal Genomics is a wholly owned subsidiary of Courtagen Life Sciences, Inc. For more information, please visit http://www.medicinalgenomics.com/
About Courtagen Life Sciences, Inc.
Courtagen Life Sciences, Inc., located in Woburn, MA, is a CLIA/CAP certified molecular information company focused on the diagnosis of a range of neurological disorders. Courtagen operates a highly sophisticated Next Generation DNA Sequencing, bioinformatics, and clinical interpretation business. Courtagen’s work helps physicians elucidate the linkages between the genotypes and phenotypes of various neurological diseases. For more information, please visit http://www.courtagen.com/